Investment Analysis News 30 December 2025

Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up

NEW YORK, December 30, 2025, 14:50 ET — Regular session Shares of lululemon athletica inc. fell about 0.6% to $211.30 in afternoon trading on Tuesday after founder Chip Wilson launched a proxy fight — a campaign to win shareholder votes

30 December 2025

Business News·Corporate Governance·Investment Analysis·Retail Industry·Stock Market

Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

NEW YORK, December 30, 2025, 14:40 ET — Regular session Shares of Cogent Biosciences, Inc. fell 2.7% to $36.88 on Tuesday after the biotech said it submitted a New Drug Application to the U.S. Food and Drug Administration for its

30 December 2025

Biotech Industry·FDA News·Investment Analysis·Pharmaceuticals·Stock Market

Schwab stock slips as Fed minutes put rate outlook back in focus

NEW YORK, December 30, 2025, 14:00 ET — Regular session The Charles Schwab Corp’s shares were down 0.6% at $100.69 in afternoon trading on Tuesday, after opening at $101.58 and trading between $100.34 and $101.60. The broader market was little

30 December 2025

Federal Reserve·Financial News·Interest Rates·Investment Analysis·Stock Market

GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy

NEW YORK, December 30, 2025, 1:54 PM ET — Regular session Genmab A/S’s U.S.-listed shares (GMAB) fell 3.3% to $31.45 in Tuesday’s regular session. The stock traded between $31.40 and $32.06 after opening at $31.98, with about 1.9 million shares

30 December 2025

Biotech News·Cancer Research·Investment Analysis·Pharmaceutical Industry·Stock Market

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

NEW YORK, December 30, 2025, 13:38 ET — Regular session Shares of Mineralys Therapeutics Inc fell 3.3% to $35.61 by early afternoon on Tuesday, after touching a session low of $35.17. About 513,000 shares had changed hands, versus a previous

30 December 2025

Biotech Stocks·FDA News·Investment Analysis·Pharmaceutical Industry·Stock Market

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

NEW YORK, December 30, 2025, 13:14 ET — Regular session Corcept Therapeutics Inc shares fell 8.9% to $72.72 in early afternoon Nasdaq trading on Tuesday, after touching a session low of $72.26. The stock was last down $7.10 from Monday’s

30 December 2025

Biotech News·FDA Approvals·Investment Analysis·Pharmaceutical Industry·Stock Market

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

NEW YORK, December 30, 2025, 12:33 ET — Regular session Edgewise Therapeutics shares were up 0.2% at $24.68 as of 12:18 p.m. ET on Tuesday, after a Form 144 filing showed company officer Robert Michael Carruthers sold 116,665 shares worth

30 December 2025

Biotech News·Financial Updates·Insider Trading·Investment Analysis·Stock Market

Bank of America (BAC) stock today: Shares slip as Fed minutes, year-end funding strains grab focus

NEW YORK, December 30, 2025, 11:54 ET — Regular session Bank of America Corp shares were down 0.2% at $55.23 by 11:54 a.m. ET, after trading between $55.20 and $55.64. About 6.5 million shares had changed hands. The move came

30 December 2025

Bank Stocks·Federal Reserve·Financial News·Investment Analysis·Stock Market

Eli Lilly stock dips after report flags China price cuts for Mounjaro

NEW YORK, December 30, 2025, 10:48 ET — Regular session Eli Lilly and Company shares were down $1.73, or about 0.2%, at $1,077.00 in morning trading on Tuesday. The move comes as investors focus on whether the weight-loss boom is

30 December 2025

Investment Analysis·Pharmaceuticals·Stock Market

JPMorgan stock slips in early trade as Fed minutes and year-end funding signals take focus

NEW YORK, December 30, 2025, 10:25 ET — Regular session JPMorgan Chase & Co shares edged down 0.2% to $323.18 in late morning trading on Tuesday, after touching an intraday high of $324.89. U.S. bank stocks were mixed, with Bank

30 December 2025

Banking·Federal Reserve·Financial News·Investment Analysis·Stock Market

Palantir stock slips today as Fed minutes loom and AI-linked tech cools

NEW YORK, December 30, 2025, 10:17 ET — Regular session Palantir Technologies (PLTR.O) slipped in morning trading on Tuesday, down $1.27, or about 0.7%, at $182.91. The stock has traded between $181.78 and $185.11 so far in the session. The

30 December 2025

Artificial Intelligence·Federal Reserve·Investment Analysis·Stock Market·Technology News

Micron stock rises in premarket after CFO trust transfer filing; what MU traders are watching next

NEW YORK, December 30, 2025, 07:04 ET — Premarket Micron Technology, Inc. (MU) shares rose 1.1% in premarket trading on Tuesday to $297.57, after the stock climbed 3.4% to close at $294.37 in the prior session, as investors weighed a

30 December 2025

Financial News·Investment Analysis·Stock Market·Trading Strategies